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Abstract
Background: This paper presents findings from the Tobacco Control in Arizona Healthcare
Systems Survey, conducted in 2000. The purpose of the survey was to assess the status of Arizona
healthcare systems' awareness and implementation of tobacco cessation and prevention measures.
Methods:  The 20-item survey was developed by The University of Arizona HealthCare
Partnership in collaboration with the Arizona Department of Health Services Bureau of Tobacco
Education and Prevention. It was mailed to representatives of Arizona's 40 healthcare systems,
including commercial and Medicare managed care organizations, "managed Medicaid" organizations,
Veterans Affairs Health Care Systems, and Indian Health Service Medical Centers. Thirty-three
healthcare systems (83%) completed the survey.
Results: The majority of healthcare systems reported awareness of at least one tobacco cessation
and prevention clinical practice guideline, but only one third reported full guideline implementation.
While a majority covered some form of behavioral therapy, less than half reported covering
tobacco treatment medications. "Managed Medicaid" organizations administered through the
Arizona Health Care Cost Containment System were significantly less likely to offer coverage for
behavioral therapy and less likely to cover pharmacotherapy than were their non-Medicaid
counterparts in managed care, Veterans Affairs Health Care Systems and Indian Health Service
Medical Centers.
Conclusion: Arizona healthcare system coverage for tobacco cessation in the year 2000 was
comparable to national survey findings of the same year. The findings that only 10% of "Managed
Medicaid" organizations covered tobacco treatment medication and were significantly less likely to
cover behavioral therapy were important given the nearly double smoking prevalence among
Medicaid patients. Throughout the years of the program, the strategic plan of the Arizona
Department of Health Services Bureau of Tobacco Education and Prevention has included the goal
of identifying and eliminating tobacco related disparities for special populations, including low-
income groups. Of importance, in 2008 the Arizona Health Care Cost Containment System was
authorized to provide tobacco cessation pharmacotherapy as a covered benefit for its members.
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Background
In 1995, the Arizona Department of Health Services
(ADHS) launched its first comprehensive public Tobacco
Education and Prevention Program (TEPP). The name was
changed to Bureau of Tobacco Education and Prevention
(BTEP) in 2007. Since ADHS-BTEP's inception, Arizona's
overall adult smoking rate declined by 23% between 1994
and 2006, from 23.5% to 18.1% [1]. The 2006 prevalence
was 13% below the U.S. average of 20.8% for that year [2].
The cost of tobacco dependence is both human and finan-
cial: it is the leading preventable cause of death and illness
in the United States [3], creating an estimated $96 billion
in healthcare expenditures and causing $97 billion in
annual productivity losses [4]. In Arizona alone, annual
tobacco-related costs exceed $1.3 billion in healthcare
expenditures and $1.49 billion in productivity losses [4].
Compared with other preventive disease interventions,
tobacco dependence treatment has been shown to be both
clinically efficacious and cost-effective [5-7]. Therefore,
substantial incentives exist for healthcare systems, health
insurers, and health plan purchasers to systematically
include tobacco dependence treatment as a covered bene-
fit. Managed care organizations (MCOs) provide a frame-
work for this systematic inclusion with an emphasis on
cost-effective treatment. Likewise, purchasers of health
plans potentially have the power to influence healthcare
delivery by requesting tobacco dependence treatment
services and tracking quality of care and health outcomes.
By reducing expenditures for preventable conditions and
appealing to purchasers and consumers who value pre-
ventive initiatives [8], public health services and tobacco
dependence clinical practice guidelines address the needs
of MCOs and health plan purchasers alike. Conducted in
2000, the Tobacco Control in Arizona Healthcare Systems
Survey arose from the need to clarify and address the rela-
tionship among healthcare systems, existing evidence-
based guidelines, and public health services for tobacco
dependence treatment. The sponsoring organization was
The University of Arizona HealthCare Partnership, ADHS-
TEPP's continuing education and certification arm, pro-
viding planning and evaluation of tobacco dependence
treatment outreach programs, and treatment certification
for health and human service professionals, health influ-
encers, and local communities statewide.
By the year 2000, Arizona represented one of the most
heavily penetrated managed care markets in the United
States in both commercial and Medicare MCOs. It was the
first state to implement a "managed Medicaid" system, the
Arizona Health Care Cost Containment System (AHC-
CCS). In addition, Arizona has had a traditionally strong
tobacco control program and was the first state to estab-
lish public smoking bans, in 1972.
Representing the Arizona State Legislature's response to
overwhelming county costs for indigent healthcare, AHC-
CCS was created in 1982 to " [open] up the private physi-
cian network to Medicaid recipients and [allow] AHCCCS
members to choose a Health Plan and a Primary Care Pro-
vider" [9]. Similar to private health insurance, AHCCCS
gives patients a choice of health plans that operate on cor-
porate or governmental, for-profit or non-profit bases,
depending on the parent organization [9]. AHCCCS capi-
tates monthly payments to its health plans for arrange-
ment of healthcare delivery [10].
The Tobacco Control in Arizona Healthcare Systems Sur-
vey was modeled on the series of national surveys first
conducted in 1997 as part of the Robert Wood Johnson
Foundation's Addressing Tobacco in Managed Care initi-
ative [11]. The Arizona survey shared several objectives
with the 1997 national survey, including the assessment
of healthcare systems' awareness and practice related to
evidence-based tobacco dependence treatment guidelines
and the identification of barriers they faced in their efforts
to systematically include tobacco dependence treatment
[11]. Additionally, the Tobacco Control in Arizona
Healthcare Systems Survey aimed to assess healthcare sys-
tems' awareness and practice related to tobacco depend-
ence treatment resources, including those offered by
ADHS-TEPP. A salient goal for the 2000 survey was to gen-
erate baseline data on Arizona healthcare systems for
comparison with a projected follow-up survey. Research-
ers hoped to further elucidate findings related to Arizona's
presence as the first managed Medicaid system in the
United States and generate comparisons with national
data taken at the time.
Methods
Survey timing and development
The year 2000 presented an historical time to conduct the
Tobacco Control in Arizona Healthcare Systems Survey.
This year marked the publication of The Clinical Practice
Guideline: Treating Tobacco Use and Dependence, released
in June 2000 by the U.S. Public Health Service. Other evi-
dence-based guidelines were also available to promote
and encourage development of healthcare system policies
for tobacco dependence treatment, including the Agency
for Healthcare Policy and Research's Smoking Cessation
Clinical Practice Guideline No. 18 (the 1996 precursor to
Treating Tobacco Use and Dependence) and evidence-based
recommendations developed by the National Cancer
Institute and the Veterans Affairs Health Care System. The
2000 Clinical Practice Guideline, in particular, drew from
an exhaustive search of the available literature to recom-
mend that all tobacco users receive treatment in accord-
ance with their readiness to quit, that clinicians and
healthcare systems standardize the identification and doc-
umentation of all tobacco users who present in a health-Health Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
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care setting, and that health plans and purchasers ensure
reimbursement for clinically effective behavioral and
pharmacotherapeutic treatments for tobacco dependence
[12]. Given the various evidence-based guidelines availa-
ble at the time, the degree of their awareness and imple-
mentation into Arizona healthcare systems was uncertain.
In existence since 1995, the ADHS-TEPP program was well
established by 2000. ADHS-TEPP was tasked with bring-
ing the Arizona healthcare community up to speed with
the accelerating changes in tobacco dependence treat-
ment. Awareness and implementation of public preven-
tion and treatment resources in 2000 would establish a
knowledge base for assessing program progress in subse-
quent years.
The Master Settlement Agreement (MSA) of 1998 brought
into sharp focus the need to monitor delivery of health
services for the prevention or treatment of tobacco
dependence. Anti-tobacco momentum had reached a
threshold whereby state governments needed to take
stock of clinical skills and resources available for tobacco
dependence treatment.
The 20-item survey was developed by the University of
Arizona HealthCare Partnership in conjunction with
ADHS-TEPP in early 2000. Health Services Advisory
Group, Inc., Arizona's healthcare quality improvement
organization, served as a consultant for the survey project.
Survey questions addressed the following domains: 1)
demographic profile of healthcare systems, including
type, enrollment, delivery model, tax status, and accredi-
tation; 2) presence of written tobacco-free workplace pol-
icies for employees and/or written tobacco cessation
protocols or policies for enrollees; 3) awareness and self-
reported implementation of tobacco dependence treat-
ment clinical practice guidelines; 4) awareness of and
referral to ADHS-TEPP cessation services; and 5) availabil-
ity of and coverage for tobacco cessation behavioral inter-
ventions and medications for enrollees (Additional File
1).
Other survey questions asked participants to 6) respond
to and rank a list of barriers to implementation of tobacco
dependence treatment clinical practice guideline recom-
mendations, including such items as "insufficient staff,"
"cost of implementing guidelines," and "lack of requests
from plan purchasers" and 7) respond to and rank a sim-
ilar list of barriers to provision of tobacco dependence
treatment behavioral interventions and medications
(Additional File 1).
Not discussed in this article, but included in the scope of
the survey, were questions asking participants to 8)
describe methods and frequency used to measure enrollee
tobacco use; 9) respond to a list of strategies used to moti-
vate clinicians and/or their staff, including such items as
"clinician education in tobacco cessation and prevention"
and "increased reimbursement for tobacco cessation
counseling/assistance"; and 10) identify whether tobacco
dependence treatment services were offered as part of a
disease management or health promotion program (e.g.,
asthma or diabetes mellitus).
Survey implementation
Forty healthcare systems were identified within Arizona,
including
• Nine commercial MCOs,
￿ Eight Medicare MCOs,
￿ Twelve Arizona Health Care Cost Containment System
(AHCCCS) MCOs,
￿ Three Veterans Affairs (VA) Health Care Systems, and
￿ Eight Indian Health Service (IHS) Medical Centers.
In the summer of 2000, medical directors of all 40 health-
care systems received a draft survey questionnaire, as well
as a letter that apprised them of the project and asked
them to identify the appropriate individual within the
organization to whom the actual survey should be
directed. In addition, the letter explained that all
responses from individual healthcare systems would be
kept confidential, and that survey reports would reflect
aggregate data only. The 20-item questionnaire was then
mailed to the medical directors or their designees. Meas-
ures to increase response rate included reminder tele-
phone calls, follow-up postcards, and additional
questionnaire copies sent to non-respondents after initial
contact. Surveys were collected July through September
2000.
Data analysis
Responses to survey questionnaires were reported in
aggregate by healthcare system type. Descriptive analyses
of frequency measures and cross-tabulations by type of
healthcare system and dominant delivery model were
compared. Fisher's exact test was used to test whether
AHCCCS MCOs differed significantly from non-AHCCCS
commercial and Medicare MCOs in providing behavioral
therapy including and beyond self-help.
Results
Of the 40 healthcare systems contacted, 33 (83%)
responded to the survey. These included 7 commercial, 7
Medicare, 10 AHCCCS MCOs, 3 VA Health Care Systems,
and 6 IHS Medical Centers. Response rates by healthcareHealth Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
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system type were 82% for commercial and Medicare
MCOs, 83% for AHCCCS MCOs, 100% for VA Health
Care Systems, and 75% for IHS medical centers. Surveys
were completed most frequently by a Health Care Quality
Manager (24%); other responders included Medical
Directors (15%), Clinical Directors (9%), and Health
Educators (9%).
Awareness and implementation of guideline 
recommendations
Among responding healthcare systems, 88% – including
100% of non-AHCCCS MCOs, VA Health Care Systems,
and IHS Medical Centers – reported awareness of at least
one clinical practice guideline for tobacco dependence
treatment (Table 1). Two AHCCCS MCOs, representing
20% of AHCCCS respondents and 6% of total respond-
ents, reported that they were not aware of any guidelines,
while an additional two AHCCCS MCOs (20%) did not
respond to the question.
Thirty-three percent of all healthcare systems reported full
implementation of at least one clinical practice guideline,
including 10% of AHCCCS MCOs, 29% of non-AHCCCS
MCOs, 67% of VA Health Care Systems, and 67% of IHS
Medical Centers. Twenty-one percent reported partial
implementation, including 10% of AHCCCS MCOs, 36%
of non-AHCCCS MCOs, and 33% of VA healthcare sys-
tems. Eighteen percent of all responding healthcare sys-
tems reported no implementation of guidelines: 60% of
the AHCCCS MCOs and 21% of the commercial and
Medicare MCOs.
Healthcare systems reported various barriers to imple-
mentation of tobacco dependence treatment guideline
recommendations (Figure 1). The three most frequently
listed barriers were "lack of requests from plan purchas-
ers," "insufficient staff," and "cost of implementing guide-
lines." Reported barriers varied by healthcare system type;
for example, "cost of implementing guidelines" was cited
by 100% of responding VA Health Care Systems, while
"insufficient staff" was cited by 50% of AHCCCS MCOs
and IHS Medical Centers. "Lack of requests from plan pur-
chasers" was cited by 57% of non-AHCCCS MCOs.
Reimbursement coverage of tobacco dependence 
treatment interventions
Eighty-two percent of all healthcare systems reported cov-
erage of at least one form of behavioral therapy for
tobacco dependence treatment, including self-help mate-
rials (Table 2). This percentage fell to 70% for behavioral
therapy beyond self-help, as 12% of all healthcare systems
provided self-help materials only. AHCCCS MCOs were
significantly less likely to provide coverage for any form of
behavioral therapy including self-help, as well as for
behavioral therapy beyond self-help, than non-AHCCCS
MCOs. In addition, 30% of AHCCCS MCOs reported lack
Table 1: Awareness and implementation of tobacco dependence treatment guidelines by healthcare system type
Arizona Health Care 
Cost Containment 
System (AHCCCS) 
MCO
Non-AHCCCS MCO 
(Commercial & Medicare)
Veterans 
Affairs (VA)
Indian Health 
Service (IHS)
All Healthcare 
Systems
(Total = 10) (Total = 14) (Total = 3) (Total = 6) (Total = 33)
Awareness of 
Guidelines
N(%) N(%) N(%) N(%) N(%)
Yes 6(60) 14(100) 3(100) 6(100) 29(88)
No 2(20) 0 0 0 2(6)
No Response 2(20) 0 0 0 2(6)
Implementation of 
Guidelines
Full 1(10) 4(29) 2(67) 4(67) 11(33)
Partial 1(10) 5(36) 1(33) 0 7(21)
No 6(60) 3(21) 0 0 9(27)
No Response 2(20) 2(14) 0 2(33) 6(18)Health Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
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of coverage for any behavioral therapy for tobacco
dependence treatment.
Less than half of all responding healthcare systems (42%)
reported coverage of at least one tobacco dependence
treatment medication (Table 2). One hundred percent of
VA Health Care Systems and 83% of IHS Medical Centers
provided medication coverage, as compared to 36% of
non-AHCCCS MCOs and 10% of AHCCCS MCOs.
The three most frequently cited barriers to provision of
tobacco dependence treatment interventions, such as cov-
erage for behavioral therapies and medication, were
"insufficient staff," "insufficient funding," and "compet-
ing priorities" (Figure 2). As with implementation of prac-
tice guidelines, barriers varied by healthcare system type;
however, resource-related barriers predominated. One
hundred percent of VA Health Care Systems cited "insuf-
ficient staff" and "insufficient funding" as barriers, while
67% of IHS Medical Centers cited these items as barriers.
"Insufficient staff" was also cited by 60% of AHCCCS
MCOs, followed closely by "insufficient funding" at 50%.
A lower percentage of non-AHCCCS MCOs, however,
cited these items as barriers.
Awareness of state tobacco dependence treatment 
resources
A high percentage of healthcare systems were aware of or
referred patients to the free tobacco dependence treatment
services offered through ADHS-TEPP, including the Ari-
zona Smokers' Helpline (a statewide tobacco quitline)
and local county health department projects, as well as
tribal projects and Indian Health Service initiatives
throughout the state. Fifty-eight percent of healthcare sys-
tems reported referring patients to the Arizona Smokers'
Helpline, while an additional 12% were aware of the Hel-
pline but did not refer patients to it. Non-AHCCCS (79%)
and AHCCCS (70%) MCOs were more likely to refer
Most frequently listed barriers to implementation of tobacco dependence treatment guidelines by healthcare system type Figure 1
Most frequently listed barriers to implementation of tobacco dependence treatment guidelines by healthcare 
system type.Health Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
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patients to the Helpline than were VA Health Care Sys-
tems (0%) and IHS Medical Centers (17%). Forty-five per-
cent of healthcare systems reported referring patients to
ADHS-TEPP-funded community-based projects offering
tobacco dependence treatment services, and an additional
21% reported awareness of these projects. Again, non-
AHCCCS (57%) and AHCCCS (50%) MCOs were more
likely to refer patients to local projects than were VA
Health Care Systems (0%) and IHS Medical Centers
(33%).
Discussion
A tale of two surveys
The results of the Arizona Healthcare Systems 2000 survey
were compared with the Addressing Tobacco in Managed
Care (ATMC) survey executed in 2000 [13]. Both surveys
collected and analyzed data addressing implementation
of tobacco cessation guidelines, provision of behavioral
therapy and pharmacotherapy for tobacco cessation, and
barriers to addressing tobacco dependence in healthcare
systems. The ATMC surveyed a sample of 85 national
health insurance plans. The ATMC survey did not include
VA Health Care Systems or IHS Medical Centers. Results
of the ATMC survey showed that 56.5% of plans had
implemented clinical practice guidelines for tobacco
dependence treatment. Eighty-six percent covered some
form of behavioral therapy and 69% allowed members to
self-refer to behavioral therapy. Over half (59.2%) of the
national plans fully covered at least one type of tobacco
dependence treatment medication, ranging from 13.3%
for over-the-counter and prescription nicotine replace-
ment therapies to 44% for bupropion SR, a non-nicotine
prescription medication. Approximately three-fourths of
national plans required  providers to ask new patients
about smoking status, 68.3% to deliver "strong advice" to
quit, and 36.5% to arrange follow-up visits with patients
making quit attempts.
The 2000 ATMC survey and the Arizona Healthcare Sys-
tems survey results were comparable in response rates and
findings (Table 3). In fact, no significant differences were
found in response rate, degree of implementation, and
coverage for behavioral therapy and tobacco dependence
treatment medication, as tested by χ2 test for proportions.
Though awareness of clinical practice guidelines was not
measured per se in the national survey, it could be inferred
that national awareness was at least as high as in Arizona,
given the similar extent of self-reported guideline imple-
mentation as reported nationally.
Context and future plans
The survey was undertaken during an important time in
tobacco control history. Arizona, the site of the first-ever
public smoking bans in 1972, lagged slightly but not sig-
nificantly behind the U.S. as a whole in terms of behavio-
ral therapy and medication coverage in the year 2000.
More importantly, Arizona's "Managed Medicaid" organ-
izations appeared to lag behind commercial MCOs for
coverage of behavioral therapy and tobacco dependence
treatment medication, even though tobacco use is higher
Table 2: Coverage of tobacco dependence treatment services by healthcare system type
Coverage for 
Behavioral Services
AHCCCS 
MCO
Non-AHCCCS MCO 
(Commercial & Medicare)
VA IHS All Healthcare 
Systems
P Value 
(Fisher's Exact Test)
(Total = 10)
N(%)
(Total = 14)
N(%)
(Total = 3)
N(%)
(Total = 6)
N(%)
(Total = 33)
N(%)
AHCCCS vs. 
non-AHCCCS
Behavioral Therapy
Including Self-Help
5(50) 14(100) 3(100) 5(83) 27(82) p = 0.006
Behavioral Therapy
Beyond Self-Help
3(30) 12(86) 3(100) 5(83) 23(70) p = 0.008
Self-Help Materials 
Only
2(20) 2(14) 0 0 4(12)
No 3(30) 0 0 0 3(9)
No Response 1(10) 0 0 1(17) 2(6)
Medication Coverage
Yes 1(10) 5(36) 3(100) 5(83) 14(42)
No 9(90) 7(50) 0 0 16(48)
No Response 0 2(14) 0 1(17) 4(9)Health Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
Page 7 of 9
(page number not for citation purposes)
among the medically indigent. (For instance, the 2005
national smoking rate for Medicaid patients was 36%, ver-
sus 20.6% for the general population [12,13].) Specifi-
cally, 10% of AHCCCS MCOs offered pharmacotherapy
aids for tobacco dependence treatment, though up to 40%
of their enrollees smoke. This finding suggests a misdirec-
tion of resources at that time.
According to subsequent ATMC surveys [14], health insur-
ance coverage for tobacco dependence treatment has
grown since 2000, but has leveled off in recent years.
Health plans that pay for either behavioral therapy or
tobacco treatment medication reached a maximum at
98% in 2000, and then decreased slightly to 96.2% in
2003. Face-to-face counseling reimbursement dropped
from 41.1% to 35.9% between 2000 and 2003, though
this difference probably does not suggest a significant
change in direction or policy.
Several recent developments in Arizona's tobacco control
landscape represent major policy changes that may affect
the future of tobacco dependence treatment throughout
the state. In April 2008, the Arizona Department of Health
Services Bureau of Tobacco Education and Prevention
issued its new strategic plan, which targets at-risk popula-
tions with tailored media messages directing tobacco
users to the Quitline and other prevention and treatment
resources [15]. For the foreseeable future, ADHS-BTEP's
strategic goals also include more targeted use of the Inter-
net, text messaging, and other tools to reach vulnerable
populations.
Another positive development in 2008 provides coverage
for Medicaid enrollees seeking pharmacotherapeutic
assistance with tobacco cessation. On April 29, 2008, Ari-
zona Senate Bill 1418 was signed into law, authorizing the
Medicaid program to cover tobacco dependence treat-
ment medications for eligible members [16]. This is
Most frequently listed barriers to provision of tobacco dependence treatment interventions by healthcare system type Figure 2
Most frequently listed barriers to provision of tobacco dependence treatment interventions by healthcare sys-
tem type.Health Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
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intended to reduce the impact of tobacco-related illness in
a population with high tobacco-use prevalence. Currently,
the AHCCCS Medicaid program spend $316 million each
year – 14% of its annual costs – on tobacco-related illness
[17].
Conclusion
The 2000 survey was a timely assessment and inventory of
the stock and status of tobacco control resources within
Arizona healthcare systems. Cigarette taxes and price
increases in 2002 and 2006, followed by a statewide
smoking ban in 2007, and a deluge of media coverage on
all fronts of tobacco control, have all likely stimulated
continued interest in quitting tobacco use. Whether the
current resources needed for tobacco dependency are met
by healthcare system resources is a topic left to future
research. The two new frontiers for Arizona in tobacco
dependence treatment are likely to be further treatment
for the medically indigent and primary prevention of
tobacco use in vulnerable youth.
Competing interests
MEG is a member of the Speaker's Bureau for Pfizer, Inc.
Authors' contributions
MEG conceived of the study, participated in its design and
coordination, and led the drafting of the manuscript. LJS,
LS, and RL participated in the design and execution of the
study. JMM and CF performed the statistical analysis and
drafted the manuscript. All authors read and approved the
final manuscript.
Additional material
Acknowledgements
The authors gratefully acknowledge the financial support of the Arizona 
Department of Health Services Tobacco Education and Prevention Pro-
gram, Contract No. 451120.
References
1. Centers for Disease Control and Prevention: State-specific preva-
lence of cigarette smoking among adults and quitting among
persons aged 18–35 years – United States, 2006.  MMWR Morb
Mortal Wkly Rep 2007, 56:993-996.
2. Centers for Disease Control and Prevention: Cigarette smoking
among adults – United States, 2006.  MMWR Morb Mortal Wkly
Rep 2007, 56:1157-1161.
3. McGinnis JM, Foege WH: Actual causes of death in the United
States.  JAMA 1993, 270:2207-2212.
4. Campaign for Tobacco-Free Kids: State tobacco-related costs
and revenues.   [http://www.tobaccofreekids.org/research/
factsheets/pdf/0178.pdf]. javas-
cript:PopUpMenu2_Set(Menu11252448)
5. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker TB: Cost-
effectiveness of the clinical practice recommendations in the
AHCPR guideline for smoking cessation.  JAMA 1997,
278:1759-1766.
6. Priorities for America's health: capitalizing on life-saving,
cost-effective preventive services   [http://www.prevent.org/con
tent/view/42/70/]
7. Solberg LI, Maciosek MV, Edwards NM, Khanchandani HS, Goodman
MJ: Repeated tobacco-use screening and intervention in clin-
ical practice.  Am J Prev Med 2006, 31:62-71.
Additional file 1
Survey questions discussed in this article.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1478-
4505-6-13-2-S1.pdf]
Table 3: Results of the 2000 Arizona survey compared with the 2000 national survey
National Survey Arizona Survey Comparison
(McPhillips-Tangum et al., 2002)
(Gilles et al., 2008)
Chi Square Significance Level
Size of Initial Mail-Out 136 40
Response Rate 62.5% 83.0% 0.029 0.865
Awareness of Guidelines NA 88.0% NA NA
Implementation of 
Guidelines
56.5% 54.0% 0.001 0.981
Full Coverage At Least One Tobacco 
Treatment Medication
59.2% 42.0% 0.029 0.866
At Least One Behavioral 
Intervention
86.2% 70.0% 0.017 0.897Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health Research Policy and Systems 2008, 6:13 http://www.health-policy-systems.com/content/6/1/13
Page 9 of 9
(page number not for citation purposes)
8. Mays GP, Halverson PK, Kaluzny AD, Norton EC: How managed
care plans contribute to public health practice.  Inquiry 2000,
37:389-410.
9. Arizona Health Care Cost Containment System: Arizona Health
Care Cost Containment System Overview, October 1, 2004
through September 30, 2005.   [http://www.azahcccs.gov/publica
tions/overview/2005/AHCCCS_Overview2005.pdf].
10. McCall N, Wrightson CW, Paringer L, Trapnell G: Managed Med-
icaid cost savings: the Arizona experience.  Health Aff (Millwood)
1994, 13:234-235.
11. McPhillips-Tangum C: Results from the first annual survey on
addressing tobacco in managed care.  Tob Control 1998, 7
Suppl:S11-S13.
12. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz
ER, Heyman RB, Jaen CR, Kottke TE, Lando HA, Mecklenburg RE,
Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Villejo
L, Wewers ME: Treating Tobacco Use and Dependence: Clinical Practice
Guideline Rockville, MD: United States Department of Health and
Human Services; 2000. 
13. McPhillips-Tangum C, Cahill A, Bocchino C, Cutler C: Addressing
tobacco in managed care: results of the 2000 survey.  Prev Med
Manag Care 2002, 3:85-94.
14. McPhillips-Tangum C, Rehm B, Carreon R, Erceg CM, Bocchino C:
Addressing tobacco in managed care: results of the 2003 sur-
vey.  Prev Chronic Dis 2006, 3(3):A87.
15. Arizona Department of Health Services Bureau of Tobacco Education
and Prevention: Strategic plan for a tobacco-free Arizona.
[http://www.azdhs.gov/phs/tepp/pdf/TheStrategicPlan.pdf].
16. Arizona Senate approves smoking cessation treatments for
state Medicaid beneficiaries   [http://www.insurancenews
net.com/artie.asp?n=1&neID=200803181680.2_cb8e00328ba584a2]
17. Governor Napolitano signs smoking cessation bill, measure
will provide treatments to eligible Medicaid members   [http:/
/www.bio-medicine.org/medicine-news-1/Governor-Napolitano-
Signs-Smoking-Cessation-Bill-18114-1/]